Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$839M |
| 2 |
Amazon
AMZN
|
+$810M |
| 3 |
Tesla
TSLA
|
+$644M |
| 4 |
TSMC
TSM
|
+$546M |
| 5 |
Johnson & Johnson
JNJ
|
+$389M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
JPMorgan Chase
JPM
|
+$335M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$317M |
| 5 |
ASML
ASML
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.84% |
| 2 | Technology | 15.57% |
| 3 | Consumer Discretionary | 11.88% |
| 4 | Consumer Staples | 10.09% |
| 5 | Financials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
N-able
NABL
$650M
| $1.38M | ﹤0.01% |
134,300
+65,600
| +95% | +$700K |
|
|
TRIB
2327
Trinity Biotech
TRIB
$7.88M
| $1.38M | ﹤0.01% |
9,290
-298
| -3% | -$54.2K |
|
|
KRON
2328
DELISTED
Kronos Bio
KRON
| $1.37M | ﹤0.01% |
848,300
+152,298
| +22% | +$351K |
|
2329
VanEck Semiconductor ETF
SMH
$72.4B
| $1.36M | ﹤0.01% |
13,434
-222,400
| -94% | -$22.6M |
|
2330
Lakeland Financial Corp
LKFN
$1.55B
| $1.36M | ﹤0.01% |
+18,651
| New | +$1.43M |
|
2331
Noodles & Co
NDLS
$107M
| $1.36M | ﹤0.01% |
30,973
+4,838
| +19% | +$212K |
|
|
SCTL
2332
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $1.36M | ﹤0.01% |
909,817
-48,115
| -5% | -$75.6K |
|
|
GAU
2333
Galiano Gold
GAU
$547M
| $1.35M | ﹤0.01% |
2,604,991
+225,338
| +9% | +$119K |
|
2334
ICU Medical
ICUI
$4.58B
| $1.35M | ﹤0.01% |
8,600
-38,600
| -82% | -$5.87M |
|
2335
Aaon
AAON
$7.24B
| $1.35M | ﹤0.01% |
26,936
-6,150
| -19% | -$287K |
|
2336
AstroNova
ALOT
$227M
| $1.35M | ﹤0.01% |
105,242
-6,300
| -6% | -$74.9K |
|
2337
Eastman Chemical
EMN
$8.47B
| $1.35M | ﹤0.01% |
+16,540
| New | +$1.33M |
|
|
MBCN
2338
DELISTED
Middlefield Banc Corp
MBCN
| $1.35M | ﹤0.01% |
49,112
-4,901
| -9% | -$140K |
|
2339
loanDepot
LDI
$303M
| $1.34M | ﹤0.01% |
815,300
-138,606
| -15% | -$212K |
|
|
OSG
2340
DELISTED
Overseas Shipholding Group Inc.
OSG
| $1.34M | ﹤0.01% |
465,479
+13,200
| +3% | +$38.3K |
|
2341
Korro Bio
KRRO
$196M
| $1.34M | ﹤0.01% |
6,979
-410
| -6% | -$42.2K |
|
2342
Kenon Holdings
KEN
$3.46B
| $1.34M | ﹤0.01% |
40,700
-8,313
| -17% | -$299K |
|
|
NETI
2343
DELISTED
Eneti Inc.
NETI
| $1.34M | ﹤0.01% |
+133,358
| New | +$1.18M |
|
2344
iShares Interest Rate Hedged Corporate Bond ETF
LQDH
$540M
| $1.34M | ﹤0.01% |
+14,800
| New | +$1.34M |
|
2345
iShares US Healthcare Providers ETF
IHF
$1.27B
| $1.34M | ﹤0.01% |
+25,000
| New | +$1.34M |
|
2346
AMREP Corp
AXR
$119M
| $1.34M | ﹤0.01% |
115,800
+600
| +0.5% | +$6.89K |
|
|
PLYA
2347
DELISTED
Playa Hotels & Resorts
PLYA
| $1.34M | ﹤0.01% |
204,800
-84,500
| -29% | -$502K |
|
2348
Cerus
CERS
$601M
| $1.33M | ﹤0.01% |
365,500
+75,100
| +26% | +$283K |
|
2349
Kewaunee Scientific
KEQU
$105M
| $1.33M | ﹤0.01% |
83,611
-7,900
| -9% | -$133K |
|
2350
Flanigan's Enterprises
BDL
$90.1M
| $1.33M | ﹤0.01% |
51,499
-4,100
| -7% | -$111K |
|
Similar funds
Jim Simons's Q4 2022 Portfolio in Review
As of Q4 2022, Jim Simons held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 522 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
- Jim Simons added most to Apple in Q4 2022, an estimated $839M increase.
- Jim Simons's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
- Jim Simons fully exited Microsoft in Q4 2022, selling an estimated $891M.
- Jim Simons's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
- Jim Simons opened 626 new positions and closed 522 in Q4 2022.
- Jim Simons's portfolio value rose 3.4% quarter-over-quarter to $73.1B.
Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.